-
1Academic Journal
المؤلفون: Suzuki, Eriko1 (AUTHOR) suzueri6241980@gmail.com, Sueki, Akitsugu1 (AUTHOR), Takahashi, Hitoshi1 (AUTHOR), Ishigooka, Jun1 (AUTHOR), Nishimura, Katsuji1 (AUTHOR)
المصدر: International Journal of Neuroscience. Oct2024, p1-6. 6p.
مصطلحات موضوعية: *MENTAL depression, *DULOXETINE, *INFLAMMATION, *INTERLEUKIN-6, *ANTIDEPRESSANTS
-
2Academic Journal
Alternate Title: Fibromiyaljide Duloksetin Kaynaklı Uyku Bruksizmi ve Diş Kırılması.
المؤلفون: TUNÇEKİN, İsmail1 ismailtuncekin@gmail.com, TOPRAK, Murat2
المصدر: Duzce Medical Journal. Dec2024, Vol. 26 Issue 3, p269-271. 3p.
مصطلحات موضوعية: *FIBROMYALGIA, *DULOXETINE, *SLEEP bruxism, *TREATMENT effectiveness, *AMITRIPTYLINE, *TOOTH fractures, *GENERIC drug substitution, *SYMPTOMS
-
3Report
المصدر: Identifying and Treating Depression in the Orthopaedic Trauma Population
-
4Report
المصدر: The BEST Trial: Biomarkers for Evaluating Spine Treatments
Other URLs: https://heal.nih.gov/data/public-access-data
-
5Report
المؤلفون: National Institute on Aging (NIA)
المساهمون: Alan Rathbun, Assistant Professor
المصدر: A Feasibility and Pilot Study of Combined Treatment Protocol Using Aerobic Exercise and Duloxetine in Older Adults With Symptomatic Knee Osteoarthritis and Comorbid Depression
-
6Report
المؤلفون: National Cancer Institute (NCI)
المصدر: Optimizing Neurofeedback to Treat Chemotherapy Induced Peripheral Neuropathy
-
7Report
المساهمون: Kemal GUNGORDUK, MD.
المصدر: Evaluating the Efficacy and Safety of Preoperative Administration of Duloxetine for Pain Management in Women Undergoing Hysterectomy Via Vaginal Route
-
8Report
المؤلفون: National Cancer Institute (NCI)
المصدر: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: a Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
-
9Report
المصدر: Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Pangallo BA, Zhang Q, Desaiah D, Perahia DG, Detke MJ, Kennedy SH. Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials. Curr Med Res Opin. 2010 Nov;26(11):2643-51. doi: 10.1185/03007995.2010.522157. Epub 2010 Oct 11. -
10Report
المؤلفون: National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Brigham and Women's Hospital, Mayo Clinic
المساهمون: Ajay Wasan, MD, Msc, Professor
المصدر: Proof of Concept Study to Treat Negative Affect in Chronic Low Back Pain
-
11Report
المصدر: Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty: A Double-blinded Randomized Control Trial
-
12Report
المؤلفون: Duke University, Patient-Centered Outcomes Research Institute, National Institute of Mental Health (NIMH)
المصدر: Combining Data Sources to Identify Effect Moderation for Personalized Mental Health
-
13Report
المصدر: Pain Response Evaluation of a Combined Intervention to Cope Effectively (PRECICE)
-
14Report
المؤلفون: The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
المساهمون: Kanecia Obie Zimmerman, Associate Professor of Pediatrics
المصدر: Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Job KM, Dallmann A, Parry S, Saade G, Haas DM, Hughes B, Berens P, Chen JY, Fu C, Humphrey K, Hornik C, Balevic S, Zimmerman K, Watt K. Development of a Generic Physiologically-Based Pharmacokinetic Model for Lactation and Prediction of Maternal and Infant Exposure to Ondansetron via Breast Milk. Clin Pharmacol Ther. 2022 May;111(5):1111-1120. doi: 10.1002/cpt.2530. Epub 2022 Mar 5. -
15Report
المساهمون: Denis Nam, M.D., M.Sc, Assistant Professor, Orthopedic Surgery
المصدر: A Prospective, Triple-Blind, Randomized Controlled Trial Evaluating Duloxetine on Post-Operative Outcomes Following Primary Total Knee Arthroplasty in Patients with and Without Central Sensitization
-
16Academic Journal
المؤلفون: Aghili, Mahdi1,2 (AUTHOR) aghili@tums.ac.ir, Taherioun, Maryam2 (AUTHOR), Jafari, Fatemeh2,3,4 (AUTHOR), Azadvari, Mohaddeseh5 (AUTHOR), Lashkari, Marzieh4 (AUTHOR), Kolahdouzan, Kasra2 (AUTHOR), Ghalehtaki, Reza4 (AUTHOR), Abdshah, Alireza6 (AUTHOR)
المصدر: Supportive Care in Cancer. Aug2024, Vol. 32 Issue 8, p1-9. 9p.
مصطلحات موضوعية: *DULOXETINE, *BREAST cancer, *PACLITAXEL, *CANCER patients, *NEUROPATHY
-
17Academic Journal
المؤلفون: Takeshima, Masahiro1 (AUTHOR) m.takeshima@med.akita-u.ac.jp, Umakoshi, Akise1 (AUTHOR), Omori, Yuki2 (AUTHOR), Yoshizawa, Kazuhisa1 (AUTHOR), Ogasawara, Masaya1 (AUTHOR), Kudo, Mizuki1 (AUTHOR), Itoh, Yu1 (AUTHOR), Ayabe, Naoko3 (AUTHOR), Mishima, Kazuo1 (AUTHOR)
المصدر: Psychopharmacology. Aug2024, Vol. 241 Issue 8, p1555-1563. 9p.
مصطلحات موضوعية: *DULOXETINE, *MENTAL depression, *HAMILTON Depression Inventory, *ARIPIPRAZOLE, *SOCIAL skills, *DISEASE relapse
Reviews & Products: DIAGNOSTIC & Statistical Manual of Mental Disorders (Book)
-
18Academic Journal
المؤلفون: Gao, Wenfan1,2,3,4 (AUTHOR), Gao, Yejun5,6 (AUTHOR), Xu, Yayun1,2,3,4 (AUTHOR), Liang, Jun1,2,3,4 (AUTHOR), Sun, Yanhong1,2,3,4 (AUTHOR), Zhang, Yuanyuan1,2,3,4 (AUTHOR), Shan, Feng1,2,3,4 (AUTHOR), Ge, Jinfang5,7,8 (AUTHOR) gejinfang@ahmu.edu.cn, Xia, Qingrong5,6 (AUTHOR) ahmcxqr@163.com
المصدر: BMC Psychiatry. 6/14/2024, Vol. 24 Issue 1, p1-9. 9p.
مصطلحات موضوعية: *MENTAL depression, *DULOXETINE, *CYTOKINES
-
19Report
المصدر: A Phase 3, Prospective, Adaptive, Randomized, Double-blind, Triple-masked, Parallel, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
-
20Report
المصدر: Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors
Sundar R, Bandla A, Tan SS, Liao LD, Kumarakulasinghe NB, Jeyasekharan AD, Ow SG, Ho J, Tan DS, Lim JS, Vijayan J, Therimadasamy AK, Hairom Z, Ang E, Ang S, Thakor NV, Lee SC, Wilder-Smith EP. Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Study. Front Oncol. 2017 Jan 10;6:274. doi: 10.3389/fonc.2016.00274. eCollection 2016.
Misawa S, Denda T, Kodama S, Suzuki T, Naito Y, Kogawa T, Takada M, Suichi T, Shiosakai K, Kuwabara S; MiroCIP study group. Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study). BMC Cancer. 2023 Nov 11;23(1):1098. doi: 10.1186/s12885-023-11560-4.
Jordan B, Jahn F, Sauer S, Jordan K. Prevention and Management of Chemotherapy-Induced Polyneuropathy. Breast Care (Basel). 2019 Apr;14(2):79-84. doi: 10.1159/000499599. Epub 2019 Apr 10.
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014 Dec;155(12):2461-2470. doi: 10.1016/j.pain.2014.09.020. Epub 2014 Sep 23.
Hertz DL, Childs DS, Park SB, Faithfull S, Ke Y, Ali NT, McGlown SM, Chan A, Grech LB, Loprinzi CL, Ruddy KJ, Lustberg M. Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN). Cancer Treat Rev. 2021 Sep;99:102241. doi: 10.1016/j.ctrv.2021.102241. Epub 2021 Jun 9.
Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, Kelley MR, Lavino A, Lustberg MB, Paice JA, Schneider BP, Lavoie Smith EM, Smith ML, Smith TJ, Wagner-Johnston N, Hershman DL. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol. 2020 Oct 1;38(28):3325-3348. doi: 10.1200/JCO.20.01399. Epub 2020 Jul 14.